Revolution Medicines, Inc. RVMD
- elironrasib — Non-Small Cell Lung Cancer Phase 3
- elironrasib — Colorectal Cancer Phase 1
RAS(ON) G12C (1 companies · 2 programs)
Companies with an active program directed at RAS(ON) G12C.
Companies with an active program directed at RAS(ON) G12C.